1. Ivana K Kim is an Associate Professor of Ophthalmology at Harvard Medical School (MA, USA). As a clinician scientist in the Retina Service of the Massachusetts Eye and Ear Infirmary (USA), she serves as principal investigator for several studies evaluating new treatments for retinal diseases as well as molecular genetic studies of uveal melanoma.
2. Anne Marie Lane is an Instructor in Ophthalmology at Harvard Medical School and an epidemiologist at the Massachusetts Eye and Ear Infirmary. She oversees the conduct of clinical research studies in the Retina Service, including ocular melanoma registry studies and clinical trials of several retinal diseases.
3. Helen A Shih is the Associate Medical Director of the Francis H Burr Proton Therapy Center (MA, USA) and is Chief of the Brain and Eye Tumor Services in Radiation Oncology at Massachusetts General Hospital (USA). Her research interests are in defining the role of radiation therapy in these disease sites.
4. Evangelos S Gragoudas is the Charles Whitten Professor of Ophthalmology at Harvard Medical School and the Director of the Retina Service at the Massachusetts Eye and Ear Infirmary. He pioneered the treatment of uveal melanomas with proton-beam irradiation.